(Q24245569)

English

Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks

scientific article

In more languages

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks (English)

0 references

atrial fibrillation

0 references

transient cerebral isolation

1 reference

based on heuristic

inferred from title

author name string

Maria I Aguilar

1

0 references

Robert Hart

2

0 references

language of work or name

0 references

publication date

19 October 2005

0 references

Cochrane Database of Systematic Reviews

0 references

4

0 references

CD001925

0 references

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Lessons from the Stroke Prevention in Atrial Fibrillation trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

21 January 2018

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensity of anticoagulation to prevent stroke in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001925.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD001925.PUB2

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24245569&oldid=1507602153"